Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/31/19
Recent Progress With Filgotinib Plus Latest Partnership Expansion Points To Gilead's New Solid PathSeeking Alpha • 07/16/19
Gilead Pens $5 Billion Research Deal — Why Analysts Still Want A MergerInvestors Business Daily • 07/15/19